Design and Development of Chromene-3-carboxylate Derivatives As Antidiabetic Agents: Exploring the Antidiabetic Potential Via Dual Inhibition of Angiotensin II Type 1 Receptor and Neprilysin Enzyme.
European journal of medicinal chemistry（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined